Premium
Is the Salk principle still viable for the design of an effective HIV vaccine?
Author(s) -
Lundgren JD
Publication year - 2004
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/j.1468-1293.2004.00229.x
Subject(s) - immunogen , medicine , hiv vaccine , clinical endpoint , observational study , immunology , clinical trial , adjuvant , randomized controlled trial , aids vaccines , virology , vaccine efficacy , human immunodeficiency virus (hiv) , vaccination , vaccine trial , antibody , monoclonal antibody